Yauheniya Baranchykava: Changing Lives Through Innovation in Hemophilia Care
Yauheniya Baranchykava, Hemofilia Squad Lead at Roche, shared a post on LinkedIn:
“Change the lives of people with hemophilia. That is our purpose.
This week we had the privilege of being part of the LATAM Hemophilia Meeting, along with medical specialists from all over Latin America committed to bringing the best science to their patients.
A meeting where knowledge is shared, experiences multiply and the objective is always the same: how do we get more people to access care that really transforms their lives?
Team Chile is committed to bringing science to our medical community.
Because we are convinced: the best science must reach our doctors and, through them, our patients.
Innovation in hemophilia goes far beyond reducing bleeding.
We are talking about children who can go to school without fear, adults who work, families who breathe easier.
Roche Chile’s commitment to hemophilia is real, it is continuous and it is growing.
Thanks to LATAM team, Carolina Ocampo, Josue Hidalgo G Andrea, Morales Heerlein, and their teams to make it possible and team Peru to receive us.
It was amazing!”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments